|
RESEARCH TRIANGLE PARK, N.C. (AP) - GlaxoSmithKline PLC will fight counterfeiting of an HIV medication by tagging each medicine bottle with a tiny radio beacon, the pharmaceutical company said Wednesday.
The tracking system, about the size of a postage stamp, is attached to each bottle to authenticate that the drug Trizivir was made and shipped within approved channels in the United States, said the company, which has U.S. headquarters in Research Triangle Park and Philadelphia.
The drug is listed by the National Association of Boards of Pharmacy as one of 32 drugs most susceptible to counterfeiting and theft. The company said the Food and Drug Administration has asked the pharmaceutical industry to begin tracking medications with radio frequency identification technology.
|